The Analysis of GILEAD SCIENCES, INC.'s Holdings & P&L


Currently, GILEAD SCIENCES, INC. holds 6 types of securities in its portfolio with a total value $2.5B. In the most recent quarter, they have increased their positions in RCUS (+31.4M shares, valued at $968.8M), RCUS (+31.4M shares, valued at $890.3M), GLPG (+16.7M shares, valued at $500.2M); initiated new positions in RCUS (+31.4M shares, valued at $968.8M), RCUS (+31.4M shares, valued at $890.3M), GLPG (+16.7M shares, valued at $500.2M).


1M P&L
+136.2M+7.00%
3M P&L
+478.0M+29.84%
HY P&L
+428.1M+25.91%

P&L figures are estimated based on reported 13F stock holdings and market price changes. They are approximations and may not reflect actual fund performance. Stock split events may also affect the accuracy of these calculations, and we cannot guarantee that all splits have been fully accounted for.

Top Holding Treemap

Top Industries by Value

1Biotechnology2.5B
100.0%

Top Industries by Stock Count

1Biotechnology5 stocks
100.0%
Stock Holdings
RCUS
Arcus Biosciences Inc.
New
Shares31.4M
Event2026-06-30
Filed2026-08-03
New
Shares31.4M
Event2026-08-05
Filed2026-08-07
GLPG
Lakefront Biotherapeutics
New
Shares16.7M
Event2026-06-30
Filed2026-08-03
ASMB
Assembly Biosciences Inc.
New
Shares5.0M
Event2026-06-30
Filed2026-08-03
KYTX
Kyverna Therapeutics Inc.
New
Shares4.1M
Event2026-06-30
Filed2026-08-03
Xilio Therapeutics Inc.
Xilio Therapeutics Inc.
New
Shares650.4K
Event2026-06-30
Filed2026-08-03

Call Option Holdings
No call option holdings data available

Put Option Holdings
No put option holdings data available